Insmed Short Long Term Debt Total from 2010 to 2024

INSM Stock  USD 25.10  0.17  0.68%   
Insmed Short and Long Term Debt Total yearly trend continues to be very stable with very little volatility. Short and Long Term Debt Total is likely to grow to about 1.3 B this year. During the period from 2010 to 2024, Insmed Short and Long Term Debt Total quarterly data regression pattern had sample variance of 225807.8 T and median of  55,567,000. View All Fundamentals
 
Short and Long Term Debt Total  
First Reported
2005-03-31
Previous Quarter
1.2 B
Current Value
1.4 B
Quarterly Volatility
367.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Insmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Insmed main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.1 M, Interest Expense of 80.1 M or Total Revenue of 320.5 M, as well as many exotic indicators such as Price To Sales Ratio of 13.55, Dividend Yield of 0.0 or Days Sales Outstanding of 46.8. Insmed financial statements analysis is a perfect complement when working with Insmed Valuation or Volatility modules.
  
This module can also supplement Insmed's financial leverage analysis and stock options assessment as well as various Insmed Technical models . Check out the analysis of Insmed Correlation against competitors.

Latest Insmed's Short Long Term Debt Total Growth Pattern

Below is the plot of the Short Long Term Debt Total of Insmed Inc over the last few years. It is Insmed's Short and Long Term Debt Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Insmed's overall financial position and show how it may be relating to other accounts over time.
Short Long Term Debt Total10 Years Trend
Slightly volatile
   Short Long Term Debt Total   
       Timeline  

Insmed Short Long Term Debt Total Regression Statistics

Arithmetic Mean372,255,047
Geometric Mean92,569,037
Coefficient Of Variation127.65
Mean Deviation376,889,389
Median55,567,000
Standard Deviation475,192,373
Sample Variance225807.8T
Range1.3B
R-Value0.88
Mean Square Error52729.5T
R-Squared0.78
Significance0.000012
Slope94,033,146
Total Sum of Squares3161309.1T

Insmed Short Long Term Debt Total History

20241.3 B
20231.2 B
20221.2 B
2021612.3 M
2020404.8 M
2019397 M
2018316.6 M

About Insmed Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Insmed income statement, its balance sheet, and the statement of cash flows. Insmed investors use historical funamental indicators, such as Insmed's Short Long Term Debt Total, to determine how well the company is positioned to perform in the future. Although Insmed investors may use each financial statement separately, they are all related. The changes in Insmed's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insmed's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Insmed Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Insmed. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short and Long Term Debt Total1.2 B1.3 B

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:
Check out the analysis of Insmed Correlation against competitors.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for Insmed Stock analysis

When running Insmed's price analysis, check to measure Insmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insmed is operating at the current time. Most of Insmed's value examination focuses on studying past and present price action to predict the probability of Insmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insmed's price. Additionally, you may evaluate how the addition of Insmed to your portfolios can decrease your overall portfolio volatility.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is Insmed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(5.23)
Revenue Per Share
2.199
Quarterly Revenue Growth
0.158
Return On Assets
(0.32)
Return On Equity
(14.53)
The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.